GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (NSE:AAREYDRUGS) » Definitions » Change In Receivables

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Change In Receivables?

Aarey Drugs & Pharmaceuticals's change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Aarey Drugs & Pharmaceuticals's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Aarey Drugs & Pharmaceuticals's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-12 Mil. It means Aarey Drugs & Pharmaceuticals's Accounts Receivable increased by ₹12 Mil from Mar. 2023 to Mar. 2024 .

Aarey Drugs & Pharmaceuticals's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹1,845 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aarey Drugs & Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 80.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aarey Drugs & Pharmaceuticals's liquidation value for the three months ended in Mar. 2024 was ₹-136 Mil.


Aarey Drugs & Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Change In Receivables Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.12 -658.79 257.29 -624.89 -12.00

Aarey Drugs & Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aarey Drugs & Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals  (NSE:AAREYDRUGS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aarey Drugs & Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1844.777/2103.54*91
=80.03

2. In Ben Graham's calculation of liquidation value, Aarey Drugs & Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Aarey Drugs & Pharmaceuticals's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=28.901-1722.187+0.75 * 1844.777+0.5 * 346.757
=-136

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Headlines

No Headlines